Health Care Climbs Amid Deal Intrigue - Health Care Roundup
Provided by
Dow Jones
Health-care companies rose amid deal intrigue.
Bausch + Lomb rallied after The Financial Times reported that the maker of contact lenses and other optical equipment was seeking to sell itself to extricate itself from indebted parent company Bausch.
Shares of Bausch rose on hopes that a sale of its stake in the optical health concern would alleviate debt pressures.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
September 16, 2024 17:05 ET (21:05 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk
United States